Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | %Female (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nature Reviews Drug Discovery | journal | 7.018 Q1 | 391 | 185 | 748 | 7859 | 6947 | 412 | 9.39 | 42.48 | 30.51 | |
2 | Trends in Pharmacological Sciences | journal | 4.195 Q1 | 244 | 100 | 285 | 6905 | 3003 | 261 | 10.94 | 69.05 | 29.77 | |
3 | Journal for ImmunoTherapy of Cancer | journal | 4.194 Q1 | 117 | 336 | 336 | 13307 | 3108 | 310 | 9.55 | 39.60 | 41.06 | |
4 | Neuropsychopharmacology | journal | 3.122 Q1 | 249 | 297 | 917 | 15542 | 5892 | 848 | 5.71 | 52.33 | 43.84 | |
5 | npj Vaccines | journal | 2.465 Q1 | 47 | 49 | 101 | 2565 | 551 | 99 | 5.64 | 52.35 | 43.11 | |
6 | Journal of Antimicrobial Chemotherapy | journal | 2.230 Q1 | 221 | 593 | 1697 | 17762 | 7999 | 1471 | 4.83 | 29.95 | 45.52 | |
7 | Drug Discovery Today | journal | 1.896 Q1 | 215 | 260 | 615 | 18693 | 4545 | 579 | 7.42 | 71.90 | 35.29 | |
8 | Expert Review of Vaccines | journal | 1.746 Q1 | 105 | 102 | 353 | 9704 | 1450 | 312 | 4.40 | 95.14 | 44.98 | |
9 | Expert Opinion on Therapeutic Targets | journal | 1.699 Q1 | 106 | 91 | 319 | 9499 | 1532 | 280 | 4.80 | 104.38 | 36.58 | |
10 | International Journal of Neuropsychopharmacology | journal | 1.695 Q1 | 125 | 59 | 367 | 3337 | 1646 | 355 | 4.14 | 56.56 | 37.95 | |
11 | Neuropharmacology | journal | 1.638 Q1 | 191 | 382 | 1383 | 28712 | 6314 | 1361 | 4.56 | 75.16 | 46.14 | |
12 | Clinical Trials | journal | 1.549 Q1 | 74 | 92 | 259 | 2131 | 612 | 212 | 2.07 | 23.16 | 46.78 | |
13 | PharmacoEconomics | journal | 1.453 Q1 | 118 | 123 | 348 | 5332 | 1167 | 303 | 3.08 | 43.35 | 47.73 | |
14 | Clinical Pharmacokinetics | journal | 1.417 Q1 | 184 | 121 | 351 | 6954 | 1590 | 332 | 4.34 | 57.47 | 40.51 | |
15 | British Journal of Clinical Pharmacology | journal | 1.378 Q1 | 167 | 320 | 910 | 12029 | 3394 | 776 | 3.51 | 37.59 | 40.15 | |
16 | Journal of Psychopharmacology | journal | 1.342 Q1 | 135 | 148 | 436 | 9243 | 1631 | 408 | 3.33 | 62.45 | 41.58 | |
17 | BioDrugs | journal | 1.304 Q1 | 79 | 61 | 153 | 3368 | 754 | 148 | 5.28 | 55.21 | 37.05 | |
18 | CNS Neuroscience and Therapeutics | journal | 1.241 Q1 | 91 | 140 | 364 | 7729 | 1288 | 305 | 3.61 | 55.21 | 41.80 | |
19 | Therapeutic Advances in Neurological Disorders | journal | 1.240 Q1 | 68 | 74 | 161 | 4511 | 736 | 149 | 5.20 | 60.96 | 35.81 | |
20 | Pharmaceutical Statistics | journal | 1.223 Q1 | 46 | 56 | 158 | 1581 | 228 | 154 | 1.33 | 28.23 | 26.32 | |
21 | Acta Pharmacologica Sinica | journal | 1.195 Q1 | 117 | 164 | 497 | 7653 | 2226 | 490 | 4.66 | 46.66 | 43.50 | |
22 | Expert Opinion on Investigational Drugs | journal | 1.180 Q1 | 117 | 105 | 357 | 8288 | 1472 | 338 | 4.67 | 78.93 | 40.24 | |
23 | Drug Safety | journal | 1.148 Q1 | 140 | 125 | 352 | 6758 | 1196 | 293 | 3.09 | 54.06 | 43.97 | |
24 | Expert Opinion on Therapeutic Patents | journal | 1.027 Q1 | 88 | 73 | 290 | 6360 | 1385 | 281 | 5.41 | 87.12 | 40.44 | |
25 | Pharmacogenomics Journal | journal | 0.981 Q1 | 95 | 59 | 249 | 3147 | 766 | 244 | 2.92 | 53.34 | 44.90 | |
26 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.930 Q2 | 100 | 88 | 373 | 8459 | 1290 | 343 | 3.62 | 96.13 | 48.61 | |
27 | Molecular Diagnosis and Therapy | journal | 0.921 Q2 | 68 | 65 | 184 | 5326 | 569 | 180 | 3.24 | 81.94 | 42.31 | |
28 | Expert Opinion on Biological Therapy | journal | 0.917 Q2 | 102 | 129 | 437 | 10643 | 1395 | 407 | 3.18 | 82.50 | 38.26 | |
29 | Phytotherapy Research | journal | 0.905 Q2 | 158 | 280 | 660 | 16159 | 2999 | 655 | 4.28 | 57.71 | 45.39 | |
30 | ChemMedChem | journal | 0.895 Q2 | 119 | 195 | 814 | 10943 | 2565 | 786 | 3.13 | 56.12 | 37.21 | |
31 | Drugs in Context | journal | 0.848 Q2 | 36 | 51 | 69 | 3373 | 216 | 69 | 3.57 | 66.14 | 36.11 | |
32 | Cardiovascular Therapeutics | journal | 0.839 Q2 | 54 | 26 | 192 | 1110 | 473 | 188 | 2.46 | 42.69 | 38.31 | |
33 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.808 Q2 | 92 | 171 | 617 | 8463 | 2844 | 617 | 4.83 | 49.49 | 46.63 | |
34 | Expert Opinion on Emerging Drugs | journal | 0.801 Q2 | 54 | 21 | 95 | 1879 | 300 | 90 | 3.11 | 89.48 | 46.03 | |
35 | Clinical and Experimental Pharmacology and Physiology | journal | 0.769 Q2 | 115 | 130 | 477 | 5634 | 1171 | 432 | 2.42 | 43.34 | 42.95 | |
36 | Fundamental and Clinical Pharmacology | journal | 0.766 Q2 | 85 | 81 | 205 | 2960 | 547 | 199 | 2.72 | 36.54 | 45.66 | |
37 | Antiviral Therapy | journal | 0.753 Q2 | 93 | 68 | 280 | 2206 | 510 | 270 | 1.91 | 32.44 | 46.48 | |
38 | Expert Opinion on Pharmacotherapy | journal | 0.742 Q2 | 93 | 227 | 658 | 18239 | 1740 | 595 | 2.71 | 80.35 | 36.41 | |
39 | Future Medicinal Chemistry | journal | 0.739 Q2 | 90 | 221 | 535 | 14122 | 1618 | 487 | 2.89 | 63.90 | 45.18 | |
40 | Pharmacogenomics | journal | 0.691 Q2 | 100 | 129 | 472 | 6271 | 988 | 453 | 2.07 | 48.61 | 47.85 | |
41 | Chinese Medicine | journal | 0.679 Q2 | 56 | 54 | 146 | 4068 | 467 | 144 | 3.30 | 75.33 | 40.98 | |
42 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.674 Q2 | 57 | 65 | 182 | 2972 | 412 | 174 | 2.24 | 45.72 | 33.50 | |
43 | MedChemComm | journal | 0.666 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
44 | Pharmaceutical Biology | journal | 0.655 Q2 | 88 | 99 | 764 | 3894 | 2276 | 763 | 3.04 | 39.33 | 44.23 | |
45 | Journal of Peptide Science | journal | 0.651 Q2 | 73 | 76 | 253 | 3843 | 526 | 248 | 1.90 | 50.57 | 41.54 | |
46 | Immunopharmacology and Immunotoxicology | journal | 0.635 Q2 | 61 | 78 | 171 | 3207 | 385 | 166 | 2.23 | 41.12 | 46.36 | |
47 | BMC pharmacology & toxicology | journal | 0.612 Q2 | 43 | 86 | 231 | 3344 | 493 | 230 | 1.86 | 38.88 | 41.92 | |
48 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.605 Q2 | 81 | 138 | 397 | 4389 | 885 | 368 | 1.95 | 31.80 | 45.04 | |
49 | Antiviral Chemistry and Chemotherapy | journal | 0.597 Q2 | 59 | 5 | 29 | 256 | 50 | 26 | 1.72 | 51.20 | 31.03 | |
50 | Drugs in R and D | journal | 0.585 Q2 | 54 | 32 | 135 | 1497 | 339 | 129 | 2.46 | 46.78 | 36.31 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®